Feature Channels: Parkinson’s Disease

• share
• favorite_border

People with rare genetic variants associated with Parkinson’s disease and other neurodegenerative disorders are at increased risk of developing amyotrophic lateral sclerosis (ALS), according to new research presented at the 149th Annual Meeting of the American Neurological Association (ANA). The study is the first to find that rare variants linked to other neurodegenerative diseases are associated with ALS, also known as Lou Gehrig’s disease. Researchers also found having these rare variants raises the risk of faster progression of ALS as well as shorter survival.

• share
• favorite_border

Artificial intelligence (AI) is poised to revolutionize the care of neurological diseases, from detecting tumors the human eye can’t see and using implantable devices to manage various conditions to crunching data from thousands of people with the same condition to guide the development of new treatments, according to neurologists and biomedical researchers speaking at the Presidential Symposium – Present and Future Applications of AI in Neurological Care and Research at the 149th Annual Meeting of the American Neurological Association (ANA).

• share
• favorite_border

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) found the risk of developing Parkinson’s disease was 76 percent higher among those with a history of damage to the lining of their upper gastrointestinal (GI) tract than among those without.

• share
• favorite_border

Announcement of contents of the September 2024 issue of Neurosurgical Focus

• share
• favorite_border

Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson’s disease. The study is published in the August 21, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

At 69, Hoyt “Corky” Ball knew something was wrong when his right hand began to tremble uncontrollably. His primary doctor ruled out Parkinson’s, but the prescribed medication failed to alleviate his symptoms.

• share
• favorite_border

With the help of a tiny, transparent worm called Caenorhabditis elegans, researchers have identified novel players in dopamine signaling by taking advantage of a powerful platform generated via the Million Mutation Project for the rapid identification of mutant genes based on their functional impact.

• share
• favorite_border

Corewell Health™ and Michigan State University researchers are the first in the state to use de-identified electronic health records of more than 1.5 million patients to analyze incidence rates and risk factors of mild cognitive impairment, or MCI, in rural and urban areas in West Michigan.

• share
• favorite_border

There’s some good news for people with Parkinson’s disease: The risk of developing dementia may be lower than previously thought, or dementia may occur later in the course of the disease than previously reported, according to a study published in the August 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

Researchers at the University of Minnesota, have developed a new visual diagnostic technique that can be used to advance early detection for neurodegenerative diseases like Parkinson's disease and similar diseases that affect animals, including Chronic Wasting Disease in deer.

• share
• favorite_border

The movement disorder neurology and neurosurgery team at Vanderbilt University Medical Center is set to add focused ultrasound treatment (FUS) as a new tool in the treatment of essential tremor and Parkinson’s disease.

• share
• favorite_border

The Cedars-Sinai Accelerator program will greet its 10th accelerator class, featuring 10 innovative health-tech startup companies from the United States and around the globe.

• share
• favorite_border

Researchers at seven academic medical institutions around the United States held a multicenter clinical trial, finding that bilateral focused ultrasound treatment is safe for patients who had previously undergone treatment for essential tremor. Clinical data from the trial was used for the approval of bilateral focused ultrasound thalamotomy by the US Food and Drug Administration.

• share
• favorite_border

People with Parkinson’s disease are receiving a new treatment in a clinical trial started after University of Wisconsin–Madison scientists demonstrated the safety and feasibility of the therapeutic delivery method in a study of non-human primates.

• share
• favorite_border

An automated assessment technique that uses artificial intelligence could revolutionize the management of Parkinson's disease

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

To provide more personalized treatment for Parkinson's Disease based on individuals’ disease state and progression, researchers at the University of California San Francisco (UCSF) developed a video-based analysis system enabled by machine learning (ML), to quantify and validate motor symptom severity in patients with Parkinson’s Disease (PD).